Global veterinary oncology market size, share, growth drivers, trends, opportunities & forecast 2025–2030

Global Veterinary Oncology Market Overview

• The Global Veterinary Oncology Market is valued at USD 1.7 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of cancer in pets, advancements in diagnostic imaging and targeted therapies, and rising pet ownership rates. The market is also supported by growing awareness among pet owners regarding the importance of specialized veterinary care for cancer treatment, as well as the expansion of pet insurance coverage for advanced procedures .
• Key players in this market include the United States, Canada, Germany, and the United Kingdom. These countries dominate the market due to their advanced veterinary healthcare infrastructure, high pet ownership rates, and significant investments in veterinary research and development. Additionally, the presence of leading veterinary hospitals and oncology specialists in these regions contributes to their market leadership .
• In 2023, the U.S. Food and Drug Administration (FDA) updated its regulatory framework for veterinary oncology treatments under the Animal Drug User Fee Act (ADUFA) Reauthorization, 2023, issued by the U.S. Food and Drug Administration. The updated guidelines require veterinary oncologists and pharmaceutical manufacturers to comply with rigorous safety and efficacy protocols for the approval of new oncology therapies, including preclinical and clinical evaluation, pharmacovigilance, and post-market surveillance. These measures are designed to ensure that all veterinary oncology treatments undergo comprehensive testing and evaluation before being made available to the public, thereby improving treatment outcomes and increasing consumer confidence in veterinary oncology services .

Global Veterinary Oncology Market Segmentation

By Therapy Type:The therapy type segmentation includes various treatment modalities used in veterinary oncology. The subsegments are Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Palliative Care, and Other Therapies (e.g., Photodynamic Therapy, Supportive Care). Among these, Chemotherapy is currently the leading subsegment due to its effectiveness in treating various types of cancers in pets, coupled with increasing adoption by veterinary clinics and the development of novel chemotherapeutic agents .

By Animal Type:This segmentation focuses on the types of animals receiving oncology treatments. The subsegments include Dogs (Canine), Cats (Feline), Horses (Equine), and Exotic Pets (e.g., birds, reptiles, small mammals). The Dogs (Canine) subsegment dominates the market, driven by the high incidence of cancer in dogs, the strong emotional bond pet owners have with their canine companions, and the willingness to invest in advanced cancer care for dogs .

Global Veterinary Oncology Market Competitive Landscape

The Global Veterinary Oncology Market is characterized by a dynamic mix of regional and international players. Leading participants such as VCA Animal Hospitals, Banfield Pet Hospital, BluePearl Specialty and Emergency Pet Hospital, PetCure Oncology, Animal Cancer Center, OncoPet Diagnostics, Veterinary Cancer Group, University of California, Davis – Veterinary Medical Teaching Hospital, Colorado State University Veterinary Teaching Hospital, Texas A&M University Veterinary Medical Teaching Hospital, Animal Medical Center (New York), University of Pennsylvania – Ryan Veterinary Hospital, The Ohio State University Veterinary Medical Center, North Carolina State University Veterinary Hospital, University of Florida Veterinary Hospitals contribute to innovation, geographic expansion, and service delivery in this space.

Global Veterinary Oncology Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Cancer in Pets:The incidence of cancer in pets is rising, with approximately 1 in 4 dogs and 1 in 5 cats diagnosed with some form of cancer during their lifetime. In future, it is estimated that around 6 million new cancer cases will be diagnosed in dogs alone, highlighting the urgent need for specialized veterinary oncology services. This growing prevalence drives demand for advanced treatment options and specialized care, significantly impacting the veterinary oncology market.
• Advancements in Veterinary Oncology Treatments:The veterinary oncology field is witnessing rapid advancements, with over 30 new treatment modalities introduced in the last five years. Innovations such as targeted therapies and immunotherapies have shown promising results, leading to improved survival rates. In future, the market for these advanced treatments is projected to exceed $1 billion, reflecting the increasing investment in research and development aimed at enhancing pet cancer care.
• Rising Pet Ownership and Humanization of Pets:The global pet population is expected to reach 1.5 billion in future, with pet ownership rates increasing significantly. This trend is accompanied by the humanization of pets, where owners are willing to invest in high-quality healthcare. In future, pet owners are projected to spend over $30 billion on veterinary services, including oncology, indicating a strong market growth driven by the desire for better health outcomes for pets.

Market Challenges

• High Cost of Oncology Treatments:The cost of veterinary oncology treatments can be prohibitively high, with average treatment costs ranging from $5,000 to $15,000 per pet. This financial burden limits access to necessary care for many pet owners, particularly in regions with lower average incomes. In future, it is estimated that only 20% of pet owners will be able to afford advanced oncology treatments, posing a significant challenge to market growth.
• Limited Availability of Specialized Veterinary Oncologists:There is a notable shortage of veterinary oncologists, with only about 300 board-certified specialists in the U.S. as of 2023. This scarcity leads to long wait times for appointments and limited access to specialized care, particularly in rural areas. In future, the demand for veterinary oncologists is expected to outpace supply by 40%, creating a significant challenge for the industry in meeting the needs of pet owners.

Global Veterinary Oncology Market Future Outlook

The veterinary oncology market is poised for significant transformation, driven by technological advancements and evolving treatment paradigms. The integration of telemedicine is expected to enhance access to specialized care, allowing pet owners to consult with oncologists remotely. Additionally, the trend towards personalized medicine will likely lead to more tailored treatment plans, improving outcomes. As awareness of pet cancer increases, the demand for innovative therapies and comprehensive care will continue to grow, shaping the future landscape of veterinary oncology.

Market Opportunities

• Development of Innovative Treatment Options:There is a significant opportunity for the development of novel therapies, including gene therapy and advanced immunotherapies. With an estimated $500 million allocated for research in veterinary oncology in future, these innovations could revolutionize treatment protocols and improve survival rates for pets diagnosed with cancer.
• Expansion of Telemedicine in Veterinary Oncology:The rise of telemedicine presents a unique opportunity to enhance access to veterinary oncology services. In future, it is projected that telemedicine consultations will increase by 60%, allowing pet owners to connect with specialists without geographical constraints, thereby improving patient outcomes and expanding market reach.